NASDAQ: NAUT
Nautilus Biotechnology Inc Stock Ownership - Who owns Nautilus Biotechnology?

Insider buying vs selling

Have Nautilus Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anna MowryCFO and Treasurer2025-05-2915,000$0.77
$11.49kBuy
Parag MallickChief Scientist2025-05-121,500$0.73
$1.10kBuy
Parag MallickChief Scientist2025-05-0812,000$0.73
$8.78kBuy
Sujal M. PatelCEO President and Secretary2025-03-2023,933$1.00
$23.89kBuy
Sujal M. PatelCEO President and Secretary2025-03-1953,300$1.00
$53.03kBuy
Mary E. GodwinSenior VP Operations2024-09-2347,031$0.46
$21.63kBuy
Mary E. GodwinSenior VP Operations2024-09-2347,031$2.87
$134.74kSell
Mary E. GodwinSenior VP Operations2024-09-1735,000$0.46
$16.10kBuy
Mary E. GodwinSenior VP Operations2024-09-1735,000$2.85
$99.86kSell

1 of 1

NAUT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NAUT insiders and whales buy or sell their stock.

NAUT Shareholders

What type of owners hold Nautilus Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Parag Mallick16.25%20,493,392$15.41MInsider
Sujal M. Patel15.10%19,050,267$14.33MInsider
Ah Equity Partners Bio II LLC13.99%17,653,917$13.28MInsider
Vijay Satyanand Pande13.99%17,653,917$13.28MInsider
Ah Capital Management LLC13.99%17,653,917$13.28MInstitution
Perceptive Advisors LLC9.98%12,594,211$9.47MInstitution
Perceptive Advisors LLC7.22%9,111,151$6.85MInsider
Cercano Management LLC5.69%7,172,985$5.39MInstitution
Matthew S. McIlwain5.14%6,479,845$4.87MInsider
Madrona Venture Group LLC4.77%6,020,770$4.53MInstitution

1 of 3

NAUT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NAUT40.37%59.63%Net BuyingNet Buying
IOBT27.51%72.49%Net BuyingNet Buying
HURA8.37%43.24%
ANIX17.08%82.92%Net BuyingNet Buying
CRBP45.00%55.00%Net BuyingNet Selling

Nautilus Biotechnology Stock Ownership FAQ

Who owns Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ: NAUT) is owned by 49.76% institutional shareholders, 73.52% Nautilus Biotechnology insiders, and 0.00% retail investors. Parag Mallick is the largest individual Nautilus Biotechnology shareholder, owning 20.49M shares representing 16.25% of the company. Parag Mallick's Nautilus Biotechnology shares are currently valued at $16.01M.

If you're new to stock investing, here's how to buy Nautilus Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.